miR‐488‐3p Protects Cardiomyocytes against Doxorubicin‐Induced Cardiotoxicity by Inhibiting CyclinG1
Mingjing Yan(China National Pharmaceutical Group Corporation (China)), Jian Li(National Clinical Research)
Cited by 15
Related Papers
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
|Signal Transduction and Targeted Therapy|2022|1.5k
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
|Circulation|2019|346
<i>Astragalus</i>Polysaccharide Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the PI3k/Akt and p38MAPK Pathways
|Oxidative Medicine and Cellular Longevity|2014|99